| Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ... Nature medicine 24 (5), 679-690, 2018 | 1566 | 2018 |
| Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ... Cancer discovery 5 (11), 1164-1177, 2015 | 1002 | 2015 |
| Genetic and transcriptional evolution alters cancer cell line drug response U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ... Nature 560 (7718), 325-330, 2018 | 808 | 2018 |
| Targetable genetic features of primary testicular and primary central nervous system lymphomas B Chapuy, MGM Roemer, C Stewart, Y Tan, RP Abo, L Zhang, AJ Dunford, ... Blood, The Journal of the American Society of Hematology 127 (7), 869-881, 2016 | 525 | 2016 |
| The genomic landscape of pediatric Ewing sarcoma BD Crompton, C Stewart, A Taylor-Weiner, G Alexe, KC Kurek, ... Cancer discovery 4 (11), 1326-1341, 2014 | 505 | 2014 |
| Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas PK Brastianos, A Taylor-Weiner, PE Manley, RT Jones, D Dias-Santagata, ... Nature genetics 46 (2), 161-165, 2014 | 458 | 2014 |
| Institutional implementation of clinical tumor profiling on an unselected cancer population LM Sholl, K Do, P Shivdasani, E Cerami, AM Dubuc, FC Kuo, EP Garcia, ... JCI insight 1 (19), 2016 | 379 | 2016 |
| The public repository of xenografts enables discovery and randomized phase II-like trials in mice EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ... Cancer cell 29 (4), 574-586, 2016 | 328 | 2016 |
| Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma M Abedalthagafi, WL Bi, AA Aizer, PH Merrill, R Brewster, PK Agarwalla, ... Neuro-oncology 18 (5), 649-655, 2016 | 282 | 2016 |
| Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing ME Tyburczy, KA Dies, J Glass, S Camposano, Y Chekaluk, AR Thorner, ... PLoS genetics 11 (11), e1005637, 2015 | 278 | 2015 |
| Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma E Pectasides, MD Stachler, S Derks, Y Liu, S Maron, M Islam, L Alpert, ... Cancer discovery 8 (1), 37-48, 2018 | 277 | 2018 |
| Cas9 activates the p53 pathway and selects for p53-inactivating mutations OM Enache, V Rendo, M Abdusamad, D Lam, D Davison, S Pal, ... Nature genetics 52 (7), 662-668, 2020 | 216 | 2020 |
| Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma DJ Kwiatkowski, TK Choueiri, AP Fay, BI Rini, AR Thorner, G De Velasco, ... Clinical Cancer Research 22 (10), 2445-2452, 2016 | 211 | 2016 |
| Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer MB Yurgelun, AB Chittenden, V Morales-Oyarvide, DA Rubinson, ... Genetics in Medicine 21 (1), 213-223, 2019 | 190 | 2019 |
| Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing LE MacConaill, RT Burns, A Nag, HA Coleman, MK Slevin, K Giorda, ... BMC genomics 19, 1-10, 2018 | 187 | 2018 |
| BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers RP Abo, M Ducar, EP Garcia, AR Thorner, V Rojas-Rudilla, L Lin, ... Nucleic acids research 43 (3), e19-e19, 2015 | 186 | 2015 |
| Genomic landscape of high-grade meningiomas WL Bi, NF Greenwald, M Abedalthagafi, J Wala, WJ Gibson, PK Agarwalla, ... NPJ genomic medicine 2 (1), 15, 2017 | 185 | 2017 |
| Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas GM Shankar, M Abedalthagafi, RA Vaubel, PH Merrill, N Nayyar, CM Gill, ... Neuro-oncology 19 (4), 535-545, 2017 | 183 | 2017 |
| Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma ZR Qian, DA Rubinson, JA Nowak, V Morales-Oyarvide, RF Dunne, ... JAMA oncology 4 (3), e173420-e173420, 2018 | 181 | 2018 |
| Conditional MLL‐CBP targets GMP and models therapy‐related myeloproliferative disease J Wang, H Iwasaki, A Krivtsov, PG Febbo, AR Thorner, P Ernst, ... The EMBO journal 24 (2), 368-381, 2005 | 142 | 2005 |
